Antiviral medication use in a cohort of pregnant women during the 2009-2010 influenza pandemic.
Identifieur interne : 000681 ( PubMed/Checkpoint ); précédent : 000680; suivant : 000682Antiviral medication use in a cohort of pregnant women during the 2009-2010 influenza pandemic.
Auteurs : A S Yasseen [Canada] ; D B Fell [Canada] ; A E Sprague [Canada] ; R. Xie [Canada] ; G. Smith [Canada] ; M C Walker [Canada] ; S W Wen [Canada]Source :
- Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology [ 1364-6893 ] ; 2015.
Descripteurs français
- KwdFr :
- Adulte, Antiviraux (administration et posologie), Antiviraux (usage thérapeutique), Comorbidité, Complications de la grossesse et maladies infectieuses (), Complications de la grossesse et maladies infectieuses (traitement médicamenteux), Femelle, Grippe humaine (), Grippe humaine (traitement médicamenteux), Grippe humaine (épidémiologie), Grossesse, Grossesse multiple, Humains, Ontario (épidémiologie), Pandémies, Sous-type H1N1 du virus de la grippe A, Tabagisme, Vaccins antigrippaux (administration et posologie), Émigrants et immigrants, Études de cohortes.
- MESH :
- administration et posologie : Antiviraux, Vaccins antigrippaux.
- traitement médicamenteux : Complications de la grossesse et maladies infectieuses, Grippe humaine.
- usage thérapeutique : Antiviraux.
- épidémiologie : Grippe humaine, Ontario.
- Adulte, Comorbidité, Complications de la grossesse et maladies infectieuses, Femelle, Grippe humaine, Grossesse, Grossesse multiple, Humains, Pandémies, Sous-type H1N1 du virus de la grippe A, Tabagisme, Émigrants et immigrants, Études de cohortes.
English descriptors
- KwdEn :
- Adult, Antiviral Agents (administration & dosage), Antiviral Agents (therapeutic use), Cohort Studies, Comorbidity, Emigrants and Immigrants, Female, Humans, Influenza A Virus, H1N1 Subtype, Influenza Vaccines (administration & dosage), Influenza, Human (drug therapy), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Ontario (epidemiology), Pandemics, Pregnancy, Pregnancy Complications, Infectious (drug therapy), Pregnancy Complications, Infectious (prevention & control), Pregnancy, Multiple, Smoking.
- MESH :
- chemical , administration & dosage : Antiviral Agents, Influenza Vaccines.
- chemical , therapeutic use : Antiviral Agents.
- geographic , epidemiology : Ontario.
- drug therapy : Influenza, Human, Pregnancy Complications, Infectious.
- epidemiology : Influenza, Human.
- prevention & control : Influenza, Human, Pregnancy Complications, Infectious.
- Adult, Cohort Studies, Comorbidity, Emigrants and Immigrants, Female, Humans, Influenza A Virus, H1N1 Subtype, Pandemics, Pregnancy, Pregnancy, Multiple, Smoking.
Abstract
Preventing influenza-like illness (ILI) during pregnancy with antiviral medication use (AVMU) can mitigate serious health risks to mother and foetus. We report on AVMU in pregnant women in Ontario, Canada, and describe characteristics of AVMU during the 2009-2010 H1N1 pandemic. Rates and risk estimates of AVMU were compared across multiple categories and stratified across ILI infection status. Increased AVMU was observed in women with influenza infections, active smokers, those vaccinated against influenza, and those with pre-existing co-morbidities. Decreased AVMU was observed in women with multiple gestations, and those in neighbourhoods of high immigrant concentrations. Our stratified analysis indicated that the observed patterns differed by ILI infection status. We demonstrated that once infected, women across multiple groups were equally likely to use antiviral medications. In this report we also propose possible clinical explanations for the observed differences in AVMU, which will be useful in planning prevention initiatives for future pandemics.
DOI: 10.3109/01443615.2014.978846
PubMed: 25409120
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:25409120Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antiviral medication use in a cohort of pregnant women during the 2009-2010 influenza pandemic.</title><author><name sortKey="Yasseen, A S" sort="Yasseen, A S" uniqKey="Yasseen A" first="A S" last="Yasseen">A S Yasseen</name><affiliation wicri:level="1"><nlm:affiliation>a Better Outcomes Registry & Network (BORN) Ontario , Ottawa , ON , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>a Better Outcomes Registry & Network (BORN) Ontario , Ottawa , ON </wicri:regionArea><wicri:noRegion>ON </wicri:noRegion></affiliation></author><author><name sortKey="Fell, D B" sort="Fell, D B" uniqKey="Fell D" first="D B" last="Fell">D B Fell</name><affiliation wicri:level="1"><nlm:affiliation>f Children's Hospital of Eastern Ontario (CHEO), Research Institute , Ottawa , ON , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>f Children's Hospital of Eastern Ontario (CHEO), Research Institute , Ottawa , ON </wicri:regionArea><wicri:noRegion>ON </wicri:noRegion></affiliation></author><author><name sortKey="Sprague, A E" sort="Sprague, A E" uniqKey="Sprague A" first="A E" last="Sprague">A E Sprague</name><affiliation wicri:level="1"><nlm:affiliation>f Children's Hospital of Eastern Ontario (CHEO), Research Institute , Ottawa , ON , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>f Children's Hospital of Eastern Ontario (CHEO), Research Institute , Ottawa , ON </wicri:regionArea><wicri:noRegion>ON </wicri:noRegion></affiliation></author><author><name sortKey="Xie, R" sort="Xie, R" uniqKey="Xie R" first="R" last="Xie">R. Xie</name><affiliation wicri:level="1"><nlm:affiliation>b Obstetric & Maternal Newborn Investigations (OMNI) , Ottawa , ON , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>b Obstetric & Maternal Newborn Investigations (OMNI) , Ottawa , ON </wicri:regionArea><wicri:noRegion>ON </wicri:noRegion></affiliation></author><author><name sortKey="Smith, G" sort="Smith, G" uniqKey="Smith G" first="G" last="Smith">G. Smith</name><affiliation wicri:level="1"><nlm:affiliation>e Department of Obstetrics and Gynecology , Queen's University , Kingston , ON , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>e Department of Obstetrics and Gynecology , Queen's University , Kingston , ON </wicri:regionArea><wicri:noRegion>ON </wicri:noRegion></affiliation></author><author><name sortKey="Walker, M C" sort="Walker, M C" uniqKey="Walker M" first="M C" last="Walker">M C Walker</name><affiliation wicri:level="1"><nlm:affiliation>a Better Outcomes Registry & Network (BORN) Ontario , Ottawa , ON , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>a Better Outcomes Registry & Network (BORN) Ontario , Ottawa , ON </wicri:regionArea><wicri:noRegion>ON </wicri:noRegion></affiliation></author><author><name sortKey="Wen, S W" sort="Wen, S W" uniqKey="Wen S" first="S W" last="Wen">S W Wen</name><affiliation wicri:level="1"><nlm:affiliation>b Obstetric & Maternal Newborn Investigations (OMNI) , Ottawa , ON , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>b Obstetric & Maternal Newborn Investigations (OMNI) , Ottawa , ON </wicri:regionArea><wicri:noRegion>ON </wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25409120</idno><idno type="pmid">25409120</idno><idno type="doi">10.3109/01443615.2014.978846</idno><idno type="wicri:Area/PubMed/Corpus">000738</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000738</idno><idno type="wicri:Area/PubMed/Curation">000738</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000738</idno><idno type="wicri:Area/PubMed/Checkpoint">000681</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000681</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Antiviral medication use in a cohort of pregnant women during the 2009-2010 influenza pandemic.</title><author><name sortKey="Yasseen, A S" sort="Yasseen, A S" uniqKey="Yasseen A" first="A S" last="Yasseen">A S Yasseen</name><affiliation wicri:level="1"><nlm:affiliation>a Better Outcomes Registry & Network (BORN) Ontario , Ottawa , ON , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>a Better Outcomes Registry & Network (BORN) Ontario , Ottawa , ON </wicri:regionArea><wicri:noRegion>ON </wicri:noRegion></affiliation></author><author><name sortKey="Fell, D B" sort="Fell, D B" uniqKey="Fell D" first="D B" last="Fell">D B Fell</name><affiliation wicri:level="1"><nlm:affiliation>f Children's Hospital of Eastern Ontario (CHEO), Research Institute , Ottawa , ON , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>f Children's Hospital of Eastern Ontario (CHEO), Research Institute , Ottawa , ON </wicri:regionArea><wicri:noRegion>ON </wicri:noRegion></affiliation></author><author><name sortKey="Sprague, A E" sort="Sprague, A E" uniqKey="Sprague A" first="A E" last="Sprague">A E Sprague</name><affiliation wicri:level="1"><nlm:affiliation>f Children's Hospital of Eastern Ontario (CHEO), Research Institute , Ottawa , ON , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>f Children's Hospital of Eastern Ontario (CHEO), Research Institute , Ottawa , ON </wicri:regionArea><wicri:noRegion>ON </wicri:noRegion></affiliation></author><author><name sortKey="Xie, R" sort="Xie, R" uniqKey="Xie R" first="R" last="Xie">R. Xie</name><affiliation wicri:level="1"><nlm:affiliation>b Obstetric & Maternal Newborn Investigations (OMNI) , Ottawa , ON , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>b Obstetric & Maternal Newborn Investigations (OMNI) , Ottawa , ON </wicri:regionArea><wicri:noRegion>ON </wicri:noRegion></affiliation></author><author><name sortKey="Smith, G" sort="Smith, G" uniqKey="Smith G" first="G" last="Smith">G. Smith</name><affiliation wicri:level="1"><nlm:affiliation>e Department of Obstetrics and Gynecology , Queen's University , Kingston , ON , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>e Department of Obstetrics and Gynecology , Queen's University , Kingston , ON </wicri:regionArea><wicri:noRegion>ON </wicri:noRegion></affiliation></author><author><name sortKey="Walker, M C" sort="Walker, M C" uniqKey="Walker M" first="M C" last="Walker">M C Walker</name><affiliation wicri:level="1"><nlm:affiliation>a Better Outcomes Registry & Network (BORN) Ontario , Ottawa , ON , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>a Better Outcomes Registry & Network (BORN) Ontario , Ottawa , ON </wicri:regionArea><wicri:noRegion>ON </wicri:noRegion></affiliation></author><author><name sortKey="Wen, S W" sort="Wen, S W" uniqKey="Wen S" first="S W" last="Wen">S W Wen</name><affiliation wicri:level="1"><nlm:affiliation>b Obstetric & Maternal Newborn Investigations (OMNI) , Ottawa , ON , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>b Obstetric & Maternal Newborn Investigations (OMNI) , Ottawa , ON </wicri:regionArea><wicri:noRegion>ON </wicri:noRegion></affiliation></author></analytic><series><title level="j">Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology</title><idno type="eISSN">1364-6893</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Antiviral Agents (administration & dosage)</term><term>Antiviral Agents (therapeutic use)</term><term>Cohort Studies</term><term>Comorbidity</term><term>Emigrants and Immigrants</term><term>Female</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (drug therapy)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Ontario (epidemiology)</term><term>Pandemics</term><term>Pregnancy</term><term>Pregnancy Complications, Infectious (drug therapy)</term><term>Pregnancy Complications, Infectious (prevention & control)</term><term>Pregnancy, Multiple</term><term>Smoking</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Antiviraux (administration et posologie)</term><term>Antiviraux (usage thérapeutique)</term><term>Comorbidité</term><term>Complications de la grossesse et maladies infectieuses ()</term><term>Complications de la grossesse et maladies infectieuses (traitement médicamenteux)</term><term>Femelle</term><term>Grippe humaine ()</term><term>Grippe humaine (traitement médicamenteux)</term><term>Grippe humaine (épidémiologie)</term><term>Grossesse</term><term>Grossesse multiple</term><term>Humains</term><term>Ontario (épidémiologie)</term><term>Pandémies</term><term>Sous-type H1N1 du virus de la grippe A</term><term>Tabagisme</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Émigrants et immigrants</term><term>Études de cohortes</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiviral Agents</term><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ontario</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antiviraux</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Complications de la grossesse et maladies infectieuses</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term><term>Ontario</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Cohort Studies</term><term>Comorbidity</term><term>Emigrants and Immigrants</term><term>Female</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Pandemics</term><term>Pregnancy</term><term>Pregnancy, Multiple</term><term>Smoking</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Comorbidité</term><term>Complications de la grossesse et maladies infectieuses</term><term>Femelle</term><term>Grippe humaine</term><term>Grossesse</term><term>Grossesse multiple</term><term>Humains</term><term>Pandémies</term><term>Sous-type H1N1 du virus de la grippe A</term><term>Tabagisme</term><term>Émigrants et immigrants</term><term>Études de cohortes</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Preventing influenza-like illness (ILI) during pregnancy with antiviral medication use (AVMU) can mitigate serious health risks to mother and foetus. We report on AVMU in pregnant women in Ontario, Canada, and describe characteristics of AVMU during the 2009-2010 H1N1 pandemic. Rates and risk estimates of AVMU were compared across multiple categories and stratified across ILI infection status. Increased AVMU was observed in women with influenza infections, active smokers, those vaccinated against influenza, and those with pre-existing co-morbidities. Decreased AVMU was observed in women with multiple gestations, and those in neighbourhoods of high immigrant concentrations. Our stratified analysis indicated that the observed patterns differed by ILI infection status. We demonstrated that once infected, women across multiple groups were equally likely to use antiviral medications. In this report we also propose possible clinical explanations for the observed differences in AVMU, which will be useful in planning prevention initiatives for future pandemics. </div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25409120</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2015</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1364-6893</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>6</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology</Title><ISOAbbreviation>J Obstet Gynaecol</ISOAbbreviation></Journal><ArticleTitle>Antiviral medication use in a cohort of pregnant women during the 2009-2010 influenza pandemic.</ArticleTitle><Pagination><MedlinePgn>551-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3109/01443615.2014.978846</ELocationID><Abstract><AbstractText>Preventing influenza-like illness (ILI) during pregnancy with antiviral medication use (AVMU) can mitigate serious health risks to mother and foetus. We report on AVMU in pregnant women in Ontario, Canada, and describe characteristics of AVMU during the 2009-2010 H1N1 pandemic. Rates and risk estimates of AVMU were compared across multiple categories and stratified across ILI infection status. Increased AVMU was observed in women with influenza infections, active smokers, those vaccinated against influenza, and those with pre-existing co-morbidities. Decreased AVMU was observed in women with multiple gestations, and those in neighbourhoods of high immigrant concentrations. Our stratified analysis indicated that the observed patterns differed by ILI infection status. We demonstrated that once infected, women across multiple groups were equally likely to use antiviral medications. In this report we also propose possible clinical explanations for the observed differences in AVMU, which will be useful in planning prevention initiatives for future pandemics. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yasseen</LastName><ForeName>A S</ForeName><Initials>AS</Initials><Suffix>3rd</Suffix><AffiliationInfo><Affiliation>a Better Outcomes Registry & Network (BORN) Ontario , Ottawa , ON , Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>d Clinical Epidemiology Program, Ottawa Hospital Research Institute , Ottawa , ON , Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>f Children's Hospital of Eastern Ontario (CHEO), Research Institute , Ottawa , ON , Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fell</LastName><ForeName>D B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>f Children's Hospital of Eastern Ontario (CHEO), Research Institute , Ottawa , ON , Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sprague</LastName><ForeName>A E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>f Children's Hospital of Eastern Ontario (CHEO), Research Institute , Ottawa , ON , Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>b Obstetric & Maternal Newborn Investigations (OMNI) , Ottawa , ON , Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>e Department of Obstetrics and Gynecology , Queen's University , Kingston , ON , Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>M C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>a Better Outcomes Registry & Network (BORN) Ontario , Ottawa , ON , Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Obstetric & Maternal Newborn Investigations (OMNI) , Ottawa , ON , Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c Department of Obstetrics and Gynecology , University of Ottawa , Ottawa , ON , Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>d Clinical Epidemiology Program, Ottawa Hospital Research Institute , Ottawa , ON , Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>S W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>b Obstetric & Maternal Newborn Investigations (OMNI) , Ottawa , ON , Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c Department of Obstetrics and Gynecology , University of Ottawa , Ottawa , ON , Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>d Clinical Epidemiology Program, Ottawa Hospital Research Institute , Ottawa , ON , Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>218653</GrantID><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Obstet Gynaecol</MedlineTA><NlmUniqueID>8309140</NlmUniqueID><ISSNLinking>0144-3615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054242" MajorTopicYN="N">Emigrants and Immigrants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="Y">Influenza A Virus, H1N1 Subtype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011272" MajorTopicYN="N">Pregnancy, Multiple</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiviral</Keyword><Keyword MajorTopicYN="N">H1N1</Keyword><Keyword MajorTopicYN="N">Influenza</Keyword><Keyword MajorTopicYN="N">antiviral medication</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">pregnant women</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25409120</ArticleId><ArticleId IdType="doi">10.3109/01443615.2014.978846</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country></list><tree><country name="Canada"><noRegion><name sortKey="Yasseen, A S" sort="Yasseen, A S" uniqKey="Yasseen A" first="A S" last="Yasseen">A S Yasseen</name></noRegion><name sortKey="Fell, D B" sort="Fell, D B" uniqKey="Fell D" first="D B" last="Fell">D B Fell</name><name sortKey="Smith, G" sort="Smith, G" uniqKey="Smith G" first="G" last="Smith">G. Smith</name><name sortKey="Sprague, A E" sort="Sprague, A E" uniqKey="Sprague A" first="A E" last="Sprague">A E Sprague</name><name sortKey="Walker, M C" sort="Walker, M C" uniqKey="Walker M" first="M C" last="Walker">M C Walker</name><name sortKey="Wen, S W" sort="Wen, S W" uniqKey="Wen S" first="S W" last="Wen">S W Wen</name><name sortKey="Xie, R" sort="Xie, R" uniqKey="Xie R" first="R" last="Xie">R. Xie</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000681 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000681 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:25409120
|texte= Antiviral medication use in a cohort of pregnant women during the 2009-2010 influenza pandemic.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:25409120" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |